Clozapine-related tachycardia: A conundrum to identify and treat.
Australas Psychiatry
; 32(1): 84-88, 2024 Feb.
Article
en En
| MEDLINE
| ID: mdl-38165132
ABSTRACT
OBJECTIVE:
This study examined the rates and persistence of clozapine-induced tachycardia and heart-rate differences in patients treated with ß-blockers in the largest sample of patients with a psychotic disorder to date.METHOD:
An audit of medical files for 101 patients who attended a clozapine community clinic and analysis of monthly measurements of resting heart rates.RESULTS:
51% met the clinical criteria for tachycardia. Heart rates were stable over time. ß-blockers were associated with small but significant reductions in heart rates.CONCLUSION:
The cardiovascular risks of clozapine are often overlooked. ß-blockers are useful in lowering heart rates but they may be insufficient to reduce cardiac risk.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Trastornos Psicóticos
/
Clozapina
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Australas Psychiatry
Asunto de la revista:
PSIQUIATRIA
Año:
2024
Tipo del documento:
Article
País de afiliación:
Australia